Rigel Pharma slides as falling contract revenue to drive contraction
Source: SeekingAlpha
2026-03-04 13:30:37 ET
More on Rigel Pharmaceuticals
- Rigel Pharmaceuticals, Inc. (RIGL) Q4 2025 Earnings Call Transcript
- Rigel Pharmaceuticals, Inc. 2025 Q4 - Results - Earnings Call Presentation
- Rigel Pharmaceuticals: Continued Financial Performance, Catalysts In 2026
- Rigel Pharmaceuticals Q4 2025 Earnings Preview
- Top Quant rated bullish small cap stocks among companies with high short interest
Read the full article on Seeking Alpha
For further details see:
Rigel Pharma slides as falling contract revenue to drive contraction
Rigel Pharmaceuticals Inc.
NASDAQ: RIGL
RIGL Trading
-4.89% G/L:
$28.02 Last:
129,381 Volume:
$28.28 Open:
RIGL Latest News
March 03, 2026 04:01:00 pm
Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
RIGL Stock Data
$625,132,287
16,430,597
0.07%
54
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
